Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft Bill Would Overrule Supreme Court’s Device Pre-emption Support

This article was originally published in The Gray Sheet

Executive Summary

House Democrats plan to introduce a bill next month to reverse the impact of the recent Riegel v. Medtronic U.S. Supreme Court decision protecting PMA-approved devices in most cases from personal injury lawsuits
Advertisement

Related Content

Pallone Outflanks Eshoo To Win Top Dem Spot On Energy And Commerce
Consumer Groups Lobby To Reverse PMA Preemption
Consumer Groups Lobby To Reverse PMA Preemption
Anti-preemption bill resurfaces
Anti-preemption bill resurfaces
Post-Election Industry Outlook: New User Fees, More Aggressive FDA
House Democrats Hammer On Arguments Against FDA Pre-Emption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
In Victory For Device Industry, Supreme Court Favors PMA Pre-emption
Democrats Seek To Overturn Supreme Court Device Liability Decision
Advertisement
UsernamePublicRestriction

Register

MT025908

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel